Biohaven (BHVN) Cash & Equivalents (2021 - 2026)
Biohaven (BHVN) reported Cash & Equivalents of $95.75 million for Q3 2026, down 48.2% from $184.85 million a year earlier and down 59.8% from the prior quarter.
Powered by 
Analysis
Biohaven (BHVN) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Biohaven posted Cash & Equivalents of $229.96 million, up 132.0% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 22.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $99.13 million in FY2024 (-60.1%), $248.4 million in FY2023 (+21.2%), $204.88 million in FY2022 (+169.4%) and $76.06 million in FY2021 (-7.8%).
- The Q3 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q3 2024.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 35.9%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2023 (growth of 536.0%); the low point was Q3 2022 (a decline of 86.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $238.03 million (Q2 2026), $273.07 million (Q1 2026) and $229.96 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Biohaven | 2.28 Bn | 1.18 Bn | - | 95.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 95.75 Mn |
| Jun 30, 2026 | 238.03 Mn |
| Mar 31, 2026 | 273.07 Mn |
| Dec 31, 2025 | 229.96 Mn |
| Sep 30, 2025 | 184.85 Mn |
| Jun 30, 2025 | 165.80 Mn |
| Mar 31, 2025 | 98.42 Mn |
| Dec 31, 2024 | 99.13 Mn |
| Sep 30, 2024 | 84.39 Mn |
| Jun 30, 2024 | 239.15 Mn |
| Mar 31, 2024 | 182.71 Mn |
| Dec 31, 2023 | 248.40 Mn |
| Sep 30, 2023 | 111.70 Mn |
| Jun 30, 2023 | 147.61 Mn |
| Mar 31, 2023 | 125.03 Mn |
| Dec 31, 2022 | 204.88 Mn |
| Sep 30, 2022 | 50.67 Mn |
| Jun 30, 2022 | 23.21 Mn |
| Mar 31, 2022 | 40.26 Mn |
| Dec 31, 2021 | 76.06 Mn |
API Access
Biohaven Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BHVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BHVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BHVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();